BR100 Increased By (2.23%)
BR30 Increased By (2.05%)
KSE100 Increased By (1.98%)
KSE30 Increased By (2.11%)
AGHA 6.24 Increased By ▲ 0.12 (1.96%)
BECO 4.22 Increased By ▲ 0.06 (1.44%)
BML 62.00 Decreased By ▼ -0.73 (-1.16%)
BOP 31.79 Increased By ▲ 0.89 (2.88%)
CNERGY 12.07 Increased By ▲ 0.10 (0.84%)
CSIL 5.61 Increased By ▲ 0.19 (3.51%)
FCCL 58.90 Increased By ▲ 2.12 (3.73%)
FFL 13.52 Increased By ▲ 0.18 (1.35%)
FNEL 1.18 Increased By ▲ 0.03 (2.61%)
KEL 6.10 Increased By ▲ 0.10 (1.67%)
KOSM 5.56 Increased By ▲ 0.08 (1.46%)
LOTCHEM 24.79 Increased By ▲ 0.42 (1.72%)
MLCF 102.06 Increased By ▲ 4.57 (4.69%)
NBP 180.00 Increased By ▲ 5.50 (3.15%)
NCPL 49.68 Increased By ▲ 1.21 (2.5%)
NPL 51.35 Increased By ▲ 1.12 (2.23%)
OGDC 313.75 Increased By ▲ 3.28 (1.06%)
PACE 9.22 Increased By ▲ 0.17 (1.88%)
PAEL 34.26 Increased By ▲ 1.19 (3.6%)
PIBTL 13.35 Increased By ▲ 0.20 (1.52%)
PPL 220.50 Increased By ▲ 3.33 (1.53%)
PRL 86.39 Increased By ▲ 0.73 (0.85%)
PTC 49.12 Increased By ▲ 2.93 (6.34%)
SSGC 23.50 Increased By ▲ 0.18 (0.77%)
TBL 9.15 Increased By ▲ 0.13 (1.44%)
TELE 6.80 Increased By ▲ 0.07 (1.04%)
TPL 26.15 Increased By ▲ 0.05 (0.19%)
TPLP 12.76 Increased By ▲ 0.09 (0.71%)
TREET 24.13 Increased By ▲ 0.33 (1.39%)
TRG 53.87 Increased By ▲ 0.70 (1.32%)
Print Print edition: 2007-03-29

US refuses visa to Geelani

Published Updated

The United States has turned down request for visa by senior Kashmiri leader Syed Ali Shah Geelani, who wants to proceed to the US for treatment of his kidney, which has developed malignant tumour.
Media reports quoting his family members in Mumbai said on Wednesday "they were called to the US consulate in Mumbai where they were conveyed the decision of the US State Department."
Geelani underwent operation in Tata Cancer Hospital, Mumbai, a few days ago, where the doctors removed the malignant tumour successfully. Media reports quoting US embassy spokesperson confirmed that Geelani's request for visa was turned down.

Copyright Associated Press of Pakistan, 2007

Comments

Comments are closed for this article.